Academy Securities Head of Macro Strategy Peter Tchir joins Yahoo Finance’s On The Move panel to discuss market outlook, and the potential reopening of the economy amid the coronavirus pandemic....
(Bloomberg Opinion) -- If Warren Buffett’s getting long oil, that has to be bullish, right? Hold up, there, wildcatter.Despite the headline news of Berkshire Hathaway Inc. taking on another 17 million shares of Occidental Petroleum Corp., April 15 is not an auspicious day for the oil sector.The same day, the International Energy Agency published a monthly oil market report that could easily sit on the horror shelves of any bookstore in Houston (if they were open): Roughly a decade’s worth of global demand growth is set to be wiped out this year. Moreover, while the pain is most acute this quarter, the IEA expects demand in December will still be 2.7 million barrels a day lower, year over year. In an ordinary oil market, that would be deemed a catastrophe; in today’s, it represents recovery. The IEA’s projections imply more than 1.5 billion barrels of oil flowing into storage this quarter, potentially maxing...
A regional spec is a pretty broad term. How do you optimize efficiency and cost when a truck might be doing completely different work from one day to the next? ...
Gilead’s (GILD) remdesivir study in China for mild-moderate Covid-19 patients has just been suspended due to poor enrollment. The news comes as the pandemic continues to wane in China, and follows the recently announced termination of the study for severe Covid-19 patients for similar reasons.According to reports, the mild-moderate study had planned to enroll 308 patients from Wuhan- but it remains unclear exactly how many enrolled to date. The stock is currently down 3% in today’s trading, but is still up 16% year-to-date.For RBC Capital analyst Brian Abrahams this latest update is a worrying sign of the drug’s efficacy. He writes:“We continue to believe that while remdesivir showed a promising signal of activity in the recent open label compassionate use published data, the fact that no data has been revealed from the truncated severe study in China – the only randomized study thus far – despite today’s update also indicating it had enrolled...
Megan Horneman, Director of Portfolio Strategy at Verdence Capital Advisors, joins Yahoo Finance’s Alexis Christoforous, Brian Sozzi and Heidi Chung to discuss how the markets are responding to the coronavirus outbreak....
